CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
UroGen Pharma (NASDAQ: URGN), fka Theracoat, is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology. The lead drug candidates...Show all
Company (IPO / Went public)
Phone: +972-9-7707600
9 Ha’Ta’asiya St
Ra'anana, 4365007
Israel
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Name | Firm |
|---|---|
| Login to see details | Pontifax |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Material and method for treating internal cavities | Dec 01, 2016 | Apr 24, 2018 | Patent |
| Methods for treatment of bladder cancer | Apr 10, 2015 | Feb 06, 2018 | Patent |
| Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancer | Jan 20, 2015 | Oct 31, 2017 | Patent |
| Phospholipid drug analogs | Sep 29, 2015 | Jan 10, 2017 | Patent |
| Material and method for treating internal cavities | Jul 19, 2012 | May 26, 2015 | Patent |
